China’s Fragmented Healthcare System Is Becoming a Test Bed for AI at National Scale
An Asia Society webinar recap examined whether AI can help address fragmentation in China’s healthcare system. The discussion is strategically important because China offers one of the clearest real-world tests of whether AI can improve coordination, access and efficiency across a vast, uneven care landscape.
Most healthcare AI coverage remains US-centric, but the strategic story is increasingly global. Asia Society's recap of a discussion on AI and healthcare in China points to a major question: can technology meaningfully improve care in a system marked by regional disparities, uneven resource distribution and fragmented patient pathways?
China is a particularly important test case because scale changes the stakes. AI in that context is not just about point solutions or isolated pilots; it is about whether digital tools can support triage, extend specialist expertise, streamline patient routing and reduce the inefficiencies that emerge when demand clusters around top-tier urban hospitals. If AI can help there, the lessons may be applicable across other large, capacity-constrained health systems.
At the same time, fragmentation is not merely a technical problem. It reflects financing structures, institutional incentives, workforce distribution and patient behavior. AI can help with coordination and information flow, but it cannot by itself solve the structural drivers of overcrowding, access inequality or trust imbalances between different tiers of providers.
That is why China matters as more than a growth market. It is a proving ground for whether healthcare AI can function as systems infrastructure rather than as a collection of clever tools. The global takeaway may be that AI is most useful when paired with policy and workflow redesign, and least effective when asked to compensate for deep organizational fragmentation on its own.